| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Guillermo CJ et al. | Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones. | 2010 | BMC Womens Health | pmid:20507626 |
| Farish E et al. | Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. | 1991 | BMJ | pmid:1833013 |
| Fender GR et al. | Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. | 1999 | BMJ | pmid:10231255 |
| Wells M et al. | Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. | 2002 | BMJ | pmid:12153918 |
| Shakespeare J et al. | Is norethisterone a lifestyle drug? Results of database analysis. | 2000 | BMJ | pmid:10650028 |
| Spark MJ | Progest-erone, ogen, in? Which is it? | 2009 | BMJ | pmid:20044396 |
| Gault EJ et al. | Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial. | 2011 | BMJ | pmid:21493672 |
| Bryant G et al. | Is norethisterone a lifestyle drug? Health is not merely the absence of disease. | 2000 | BMJ | pmid:10896441 |
| Lloyd D | Is norethisterone a lifestyle drug? It's not a lifestyle drug in North Harrow. | 2000 | BMJ | pmid:10896442 |
| Hamilton W | Is norethisterone a lifestyle drug? The term lifestyle is not as clear as it may seem. | 2000 | BMJ | pmid:10896443 |
| Lidegaard Ø et al. | Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. | 2011 | BMJ | pmid:22027398 |
| Lidegaard Ø et al. | Hormonal contraception and risk of venous thromboembolism: national follow-up study. | 2009 | BMJ | pmid:19679613 |
| Schierbeck LL et al. | Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. | 2012 | BMJ | pmid:23048011 |
| Dexter S | Benign coital headache relieved by partner's pregnancies with implications for future treatment. | 2010 | BMJ Case Rep | pmid:22315637 |
| Jeanneret S et al. | Rendu-Osler disease: treatment with oestrogen/progestagen versus octreotide. | 2011 | BMJ Case Rep | pmid:22707551 |
| Garza-Flores J et al. | [Effectiveness of injectable contraceptives in Mexican women]. | 1985 | Bol Oficina Sanit Panam | pmid:3156612 |
| Moretti G et al. | [Simultaneous determination using gas chromatography of mestranol and norethisterone in estrogen-progestins combination for oral use]. | 1977 | Boll Chim Farm | pmid:921851 |
| Eiken P et al. | Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. | 1996 | Bone | pmid:8922661 |
| Steiniche T et al. | A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. | 1989 | Bone | pmid:2690898 |
| Cheng S et al. | Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. | 2002 | Bone | pmid:12110425 |
| Bjarnason NH et al. | Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent. | 2002 | Bone | pmid:11934658 |
| Dunn FG et al. | Malignant hypertension associated with use of oral contraceptives. | 1975 | Br Heart J | pmid:1138738 |
| Andrews E et al. | Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects. | 2008 | Br J Clin Pharmacol | pmid:18294327 |
| Walle T et al. | Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women. | 1996 | Br J Clin Pharmacol | pmid:8730976 |
| Back DJ et al. | The effects of ampicillin on oral contraceptive steroids in women. | 1982 | Br J Clin Pharmacol | pmid:6809025 |
| Walle UK et al. | The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. | 1994 | Br J Clin Pharmacol | pmid:8148214 |
| Barros D'Sa AA | The pill, mesenteric vein thrombosis and the short, short bowel syndrome. | 1980 | Br J Clin Pract | pmid:7387823 |
| CARRUTHERS GB | TRIAL OF A NEW FORM OF ORAL CONTRACEPTIVE. | 1965 | Br J Clin Pract | pmid:14324833 |
| Rowlands SC and Dakin L | Twelve years of injectable contraceptive use in a general practice. | 1998 | Br J Fam Plann | pmid:9882767 |
| Kovacs GT et al. | A pre-coital pill? A preliminary in vitro study. | 2000 | Br J Fam Plann | pmid:10920297 |
| Selby PL and Francis RM | Norethisterone in postmenopausal osteoporosis. | 1987 | Br J Hosp Med | pmid:3690084 |
| Irvine GA et al. | Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. | 1998 | Br J Obstet Gynaecol | pmid:9647148 |
| Gray RH et al. | Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility. | 1981 | Br J Obstet Gynaecol | pmid:7008825 |
| Moore B et al. | The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles. | 1981 | Br J Obstet Gynaecol | pmid:7260006 |
| Howard G et al. | The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X. | 1977 | Br J Obstet Gynaecol | pmid:889752 |
| Tayob Y et al. | Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. | 1985 | Br J Obstet Gynaecol | pmid:3902074 |
| Paul AC and Choy CC | Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. | 1999 | Br J Obstet Gynaecol | pmid:10430209 |
| Elstein M et al. | The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels. | 1976 | Br J Obstet Gynaecol | pmid:1032819 |
| Preston JT et al. | Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. | 1995 | Br J Obstet Gynaecol | pmid:7612535 |
| Toppila M et al. | Steroid receptors in human ovarian malignancy. A review of four years tissue collection. | 1986 | Br J Obstet Gynaecol | pmid:3768292 |
| Shaw RW | Assessment of medical treatments for menorrhagia. | 1994 | Br J Obstet Gynaecol | pmid:8043556 |
| Hawkins DF and Benster B | A comparative study of three low dose progestogens, chlormadinone acetate, megestrol acetate and norethisterone, as oral contraceptives. | 1977 | Br J Obstet Gynaecol | pmid:71917 |
| Jensen J et al. | Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women. | 1987 | Br J Obstet Gynaecol | pmid:3828253 |
| McCune GS | The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. | 1997 | Br J Obstet Gynaecol | pmid:9070156 |
| Coulter A and Sheldon T | The need for systematic reviews in the treatment of menstrual disorders--another Cochrane collaborative review group is born. | 1997 | Br J Obstet Gynaecol | pmid:9070157 |
| Paterson ME et al. | Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract. | 1982 | Br J Obstet Gynaecol | pmid:7104258 |
| Templeton A et al. | The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration. | 1984 | Br J Obstet Gynaecol | pmid:6696860 |
| Hammar M et al. | A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. | 1998 | Br J Obstet Gynaecol | pmid:9746385 |
| Duckitt K and Shaw RW | Is medical management of menorrhagia obsolete? | 1998 | Br J Obstet Gynaecol | pmid:9647144 |
| Sabell AG | Oral contraceptives and the contact lens wearer. | 1970 | Br J Physiol Opt | pmid:5512797 |